Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advanced Circulatory Systems, a privately held healthcare company, has received an additional $1.5 million in funding from the National Institutes of Health to continue a study testing two devices used in combination on those who experience cardiac arrest outside a hospital.
Subscribe to our email newsletter
The National Institutes of Health (NIH) funding will be used to increase enrollment in the six-site study. The study involves the testing of the ResQPump, an active compression or decompression device, in combination with the ResQPOD, a device used to increase blood flow to the heart and brain during cardiopulmonary resuscitation (CPR).
The current NIH funded study is the first randomized study in the US to assess results of the ResQPump and ResQPOD used together and comparing results when CPR is performed without these devices. Minneapolis and St Paul are two of six sites included in the national study.
The ResQPump has been tested and is currently in use in Europe. Both devices are designed and manufactured by Advanced Circulatory Systems of Minneapolis, Minnesota.